Preparation method of alpha-chloro-4-methylsulfonyl acetophenone
In the preparation method of α-chloro-4-methanesulfonylacetophenone, the compound of formula I is used to react with trimethyl orthoformate and N-chlorosuccinimide, and react with aqueous sulfuric acid, and solve the problem of low yield or purity of the preparation method in the prior art, and achieve high yield and high purity product preparation, which is suitable for industrial production.
Patent Information
- Application Number
- CN202311797360.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-26
- Publication Date
- 2025-06-27
AI Technical Summary
In the prior art, the yield or purity of the preparation method of α-bromo-4-methanesulfonylacetophenone is not high, and there is a problem of dihalogenated impurities.
Using the preparation method of α-chloro-4-methanesulfonylacetophenone, the compound of formula I is reacted with trimethyl orthoformate and N-chlorosuccinimide in an organic solvent to obtain the compound of formula II and react with aqueous sulfuric acid to obtain a high purity compound of formula III.
The high yield and high purity preparation of α-chloro-4-methanesulfonylacetophenone is achieved, and the production of dichloride impurities is avoided. It is suitable as a rofecoxib or erecoxib intermediate, and it has simple operation, mild and controllable reaction conditions, and is suitable for industrial production.
Smart Images

Figure BDA0004628081340000011 
Figure FDA0004628081330000011 
Figure FDA0004628081330000021
Abstract
Description
Technical Field
[0001] The present invention relates to a preparation method of α-chloro-4-methylsulfonylacetophenone. Background Art
[0002] α-Halo-4-methylsulfonylacetophenone is an important intermediate for rofecoxib and ericitinib. Since dichloro impurities are more likely to appear in the chlorination reaction than in the bromination reaction, most original research and pharmaceutical companies use the brominated product intermediate, that is, α-bromo-4-methylsulfonylacetophenone as the intermediate. For example, CN102206178A records that α-bromo-4-methylsulfonylacetophenone is prepared by bromination of 4-methylsulfonylacetophenone with liquid bromine in acetic acid, and the reaction yield is 80%. In CN109134318A, 4-methylsulfonylacetophenone reacts with bromine in chloroform or dichloromethane to obtain α-bromo-4-methylsulfonylacetophenone, and its purity is 98.5%. However, the preparation methods of α-bromo-4-methylsulfonylacetophenone in the prior art have low yields or purities. Therefore, it is necessary to develop a preparation method of α-halo-4-methylsulfonylacetophenone with both high yield and high purity. Summary of the Invention
[0003] The object of the present invention is to provide a preparation method of α-chloro-4-methylsulfonylacetophenone.
[0004] The first aspect of the present invention is to provide a preparation method of a compound shown in Formula III, comprising the following steps:
[0005]
[0006] Step A: Reacting a compound of Formula I with trimethyl orthoformate and N-chlorosuccinimide in an organic solvent to obtain a compound of Formula II;
[0007] Step B: Reacting the compound of Formula II with an aqueous sulfuric acid solution in an organic solvent to obtain a compound of Formula III.
[0008] In some embodiments, the organic solvent in Step A is selected from dichloromethane, methanol, acetonitrile, ethyl acetate, isopropyl acetate, and preferably methanol.
[0009] In some embodiments, the reaction temperature in Step A is 40°C to 65°C, preferably 50°C to 60°C, such as 50°C, 52°C, 55°C, 56°C, 58°C, 60°C.
[0010] In some embodiments, the mass-volume ratio of the compound of Formula I to the organic solvent in Step A, in g / ml, is 1:3 to 1:7, preferably 1:4 to 1:6, such as 1:4, 1:5, 1:6.
[0011] In some embodiments, the molar ratio of the compound of formula I to trimethyl orthoformate in step A is 1:0.5 to 1:2; preferably 1:0.8 to 1:1.2, such as 1:0.8, 1:0.85, 1:0.9, 1:1, 1:1.12, 1:1.2.
[0012] In some embodiments, the molar ratio of the compound of formula I to N-chlorosuccinimide in step A is 1:0.8 to 1:1.5; preferably 1:1.0 to 1:1.2, such as 1:05, 1:1, 1:1.15, 1:1.2.
[0013] In some embodiments, the organic solvent in step B is selected from methanol, ethanol, acetonitrile, THF, preferably methanol and ethanol, more preferably methanol.
[0014] In some embodiments, the mass-to-volume ratio of the compound of formula II to the organic solvent in step B, in g / ml, is 1:2 to 1:7, preferably 1:3 to 1:5.
[0015] In some embodiments, the reaction temperature in step B is 40°C to 70°C, preferably 55°C to 65°C, such as 55°C, 56°C, 58°C, 60°C, 62°C, 65°C.
[0016] In some embodiments, the molar ratio of the compound of formula II to sulfuric acid in step B is 1:0.3 to 1:1.0; preferably 1:0.4 to 1:0.6.
[0017] In some embodiments, step B further includes a purification step of the compound of formula III, and the specific steps are: after the reaction is completed, cool down, crystallize, filter to obtain a solid, and wash the solid with water or an organic solution; wherein the organic solvent is selected from one or more of methanol, acetonitrile, cyclohexane, n-heptane, n-hexane, methylcyclohexane, preferably ethanol.
[0018] The second aspect of the present invention is to provide a method for preparing a compound represented by formula II, comprising the following steps: reacting a compound of formula I with trimethyl orthoformate and N-chlorosuccinimide in an organic solvent to obtain a compound of formula II.
[0019] In some embodiments, the organic solvent is selected from dichloromethane, methanol, acetonitrile, ethyl acetate, isopropyl acetate, preferably methanol.
[0020] In some embodiments, the reaction temperature is 40°C to 65°C, preferably 50°C to 60°C, such as 50°C, 52°C, 55°C, 56°C, 58°C, 60°C.
[0021] In some embodiments, the mass-to-volume ratio of the compound of formula I to the organic solvent is 1:3 to 1:7, preferably 1:4 to 1:6, such as 1:4, 1:5, 1:6, in g / ml.
[0022] In some embodiments, the molar ratio of the compound of formula I to trimethyl orthoformate is 1:0.5 to 1:2; preferably 1:0.8 to 1:1.2, such as 1:0.8, 1:0.85, 1:0.9, 1:1, 1:1.12, 1:1.2.
[0023] In some embodiments, the molar ratio of the compound of formula I to N-chlorosuccinimide is 1:0.8 to 1:1.5; preferably 1:1.0 to 1:1.2, such as 1:05, 1:1, 1:1.15, 1:1.2.
[0024] The third aspect of the present invention provides a compound of formula II, which has the following structure:
[0025] Adopting the chlorination method of the present invention, the yield is high, no dichloro impurities are generated, the product purity is high, and it can be used as an intermediate for rofecoxib or etoricoxib; this method has simple operation, mild and controllable reaction conditions, can be scaled up to kilogram-scale reaction, and is suitable for industrial production. Detailed implementation manners
[0026] The following further elaborates the present invention through examples. The examples of the present invention are only used to illustrate the technical solutions of the present invention and are not used to limit the scope of the present invention. Those skilled in the art can make some non-essential improvements and adjustments, which still fall within the protection scope of the present invention.
[0027] Dichloro impurity: 2,2-dichloro-1-(4-methylsulfonylphenyl)ethan-1-one
[0028] Dibromo impurity: 2,2-dibromo-1-(4-methylsulfonylphenyl)ethan-1-one
[0029] Example 1:
[0030] 4 L of methanol, 0.54 kg of trimethyl orthoformate, 1 kg of 4-methylsulfonylacetophenone and 0.7 kg of N-chlorosuccinimide were mixed, and the reaction was carried out at 55 °C with heat preservation. After the reaction was completed, filtration was carried out to obtain compound II (purity 98.5%). Compound II was added to 4 L of methanol, and then 4 L of an aqueous solution containing 0.45 kg of sulfuric acid was added. The temperature was raised to 60 °C for reaction. After the reaction was completed, cooling crystallization and filtration were carried out. The filter cake was washed successively with water and ethanol and then dried to obtain 1.1 kg of compound III, with a yield of 93.9% (purity 99.54%, dichloro impurities not detected).
[0031] The NMR data of compound II are as follows:1 1H NMR (400 MHz, CDCl3): δ ppm 7.97 - 7.94 (m, 2H), 7.74 - 7.71 (m, 2H), 3.73 (s, 2H), 3.24 (s, 6H), 3.08 (s, 3H).
[0032] Example 2:
[0033] 400 ml of methanol, 60 g of trimethyl orthoformate, 100 g of 4 - (methylsulfonyl)acetophenone and 70 g of N - chlorosuccinimide were mixed and reacted at 55 °C with heat preservation. After the reaction was completed, filtration was carried out. The filter cake (Compound II) was added to 400 ml of methanol, and then 400 ml of an aqueous solution containing 45 g of sulfuric acid was added. The temperature was raised to 60 °C for reaction. After the reaction was completed, cooling crystallization and filtration were carried out. The filter cake was washed successively with water and ethanol and then dried to obtain 108 g of Compound III, with a yield of 92.2% (purity 99.53%, dichloro impurities not detected).
[0034] Comparative Example 1:
[0035] 500 ml of acetonitrile, 100 g of 4 - (methylsulfonyl)acetophenone, 98 g of N - bromosuccinimide and 8 g of p - toluenesulfonic acid were mixed and reacted at 60 °C with heat preservation. After the reaction was completed, through post - treatment, 118 g of α - bromo - 4 - (methylsulfonyl)acetophenone was obtained, with a yield of 85% (purity 98%, dibromo impurity content 0.67%).
[0036] Comparative Example 2:
[0037] 500 mL of acetonitrile, 100 g of 4 - (methylsulfonyl)acetophenone, 60 g of dichlorohydantoin (added in batches) and 5 g of sulfuric acid were mixed, and the temperature was raised to 60 °C for reaction. After the reaction was complete, through post - treatment, 96 g of Compound III was obtained, with a yield of 82% (purity 80.08%, dichloro impurity content 19.38%).
[0038] Dichlorohydantoin needs to be added in batches, otherwise there will be a phenomenon of sharp temperature rise during the reaction; adding in batches is not suitable for large - scale industrial production.
[0039] Comparative Example 3:
[0040] 800 mL of methanol, 100 g of 4 - (methylsulfonyl)acetophenone (1 eq), 74 g of dichlorohydantoin (added in batches) and 8 g of silica were mixed, and the temperature was raised to 60 °C for reaction. After the reaction was complete, hot filtration was carried out, and then concentration was performed to obtain Compound II. 100 mL of ethanol and 700 mL of an aqueous solution of hydrochloric acid (1.2 eq) were added for heating hydrolysis. After the reaction was complete, filtration was carried out and drying was performed to obtain 96.82 g of Compound III, with a yield of 82.6% (purity 76.22%, dichloro impurity content 20.30%).
[0041] Dichlorohydantoin needs to be added in batches, otherwise there will be a phenomenon of sharp temperature rise during the reaction; adding in batches is not suitable for industrial production.
[0042] Comparative Example 4:
[0043] 400 ml of methanol, 60 g of trimethyl orthoformate, 100 g of 4-methylsulfonylacetophenone and 70 g of N-chlorosuccinimide were mixed, and the reaction was carried out at 55 °C with heat preservation. After the reaction was completed, filtration was carried out. The filter cake (Compound II) was added with 400 mL of 3N hydrochloric acid aqueous solution and 400 ml of methanol, and the reaction was carried out at 60 °C with heat preservation. After the reaction was complete, the temperature was lowered for crystallization, filtration, and drying to obtain 101 g of Compound III, with a yield of 86% (purity 97.81%, dichloro impurity content 1.65%).
[0044] Comparative Example 5:
[0045] 2500 ml of acetonitrile, 500 g of 4-methylsulfonylacetophenone, 370 g of N-chlorosuccinimide and 48 g of p-toluenesulfonic acid were mixed, and the reaction was carried out at 50 °C with heat preservation. After the reaction was completed, the temperature was lowered for crystallization, filtration, and drying to obtain 275 g of Compound III, with a yield of 47% (purity 84.38%, dichloro impurity content 14.48%).
[0046] The method and product of the present application have been described through preferred embodiments. It is obvious to those skilled in the art that the methods and products described herein can be modified or appropriately changed and combined without departing from the content, spirit, and scope of the present application to implement the technology of the present application. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all regarded as being included in the spirit, scope, and content of the present application.
Claims
1. A method for preparing a compound represented by Formula III, characterized in that, It includes the following steps: Step A: The compound of formula I reacts with trimethyl orthoformate and N-chlorosuccinimide in an organic solvent to obtain the compound of formula II; Step B: The compound of formula II reacts with an aqueous sulfuric acid solution in an organic solvent to obtain the compound of formula III.
2. The preparation method of the compound shown in Formula III according to claim 1, characterized in that, It includes one or more of the following features: The organic solvent in Step A is selected from dichloromethane, methanol, acetonitrile, ethyl acetate, isopropyl acetate, and preferably methanol; The reaction temperature in Step A is 40°C to 65°C, preferably 50°C to 60°C, such as 50°C, 52°C, 55°C, 56°C, 58°C, 60°C; The mass-volume ratio of the compound of formula I to the organic solvent in Step A, calculated in g / ml, is 1:3 to 1:7, preferably 1:4 to 1:6, such as 1:4, 1:5, 1:6; The molar ratio of the compound of formula I to trimethyl orthoformate in Step A is 1:0.5 to 1:2; preferably 1:0.8 to 1:1.2, such as 1:0.8, 1:0.85, 1:0.9, 1:1, 1:1.12, 1:1.2; or, The molar ratio of the compound of formula I to N-chlorosuccinimide in Step A is 1:0.8 to 1:1.5; preferably 1:1.0 to 1:1.2, such as 1:05, 1:1, 1:1.15, 1:1.
2.
3. The preparation method of the compound shown in Formula III according to claim 1 or 2, characterized in that, It includes one or more of the following features: The organic solvent in Step B is selected from methanol, ethanol, acetonitrile, THF, preferably methanol and ethanol, more preferably methanol; The mass-volume ratio of the compound of formula II to the organic solvent in Step B, calculated in g / ml, is 1:2 to 1:7, preferably 1:3 to 1:5; The reaction temperature in Step B is 40°C to 70°C, preferably 55°C to 65°C, such as 55°C, 56°C, 58°C, 60°C, 62°C, 65°C; or The molar ratio of the compound of formula II to sulfuric acid in Step B is 1:0.3 to 1:1.0; preferably 1:0.4 to 1:0.
6.
4. The preparation method of the compound shown in Formula III according to any one of claims 1-3, characterized in that, Step B also includes a purification step for the compound of formula III. The specific steps are: after the reaction ends, cool down for crystallization and filtration to obtain a solid, and wash the solid with water or an organic solution; wherein the organic solvent is selected from one or more of methanol, acetonitrile, cyclohexane, n-heptane, n-hexane, methylcyclohexane, and preferably ethanol.
5. A compound of formula II having the following structure:
6. The preparation method of the compound shown in Formula II according to claim 5, characterized in that, It includes the following steps: The compound of formula I reacts with trimethyl orthoformate and N-chlorosuccinimide in an organic solvent to obtain the compound of formula II.
7. The preparation method of the compound represented by Formula II according to claim 6, characterized in that, It includes one or more of the following features: The organic solvent is selected from dichloromethane, methanol, acetonitrile, ethyl acetate, isopropyl acetate, and preferably methanol; The reaction temperature is 40°C to 65°C, preferably 50°C to 60°C, such as 50°C, 52°C, 55°C, 56°C, 58°C, 60°C; The mass-volume ratio of the compound of formula I to the organic solvent, calculated in g / ml, is 1:3 to 1:7, preferably 1:4 to 1:6, such as 1:4, 1:5, 1:6; The molar ratio of the compound of formula I to trimethyl orthoformate is 1:0.5 to 1:2; preferably 1:0.8 to 1:1.2, such as 1:0.8, 1:0.85, 1:0.9, 1:1, 1:1.12, 1:1.2; or, The molar ratio of the compound of formula I to N-chlorosuccinimide is 1:0.8 to 1:1.5; preferably 1:1.0 to 1:1.2, such as 1:05, 1:1, 1:1.15, 1:1.2.
Citation Information
Patent Citations
Method for preparing imrecoxib
CN102206178A
Preparation method of 4-(methylsulfonyl)phenyl]-1-ethanone and alpha-bromo-4-(methylsulfonyl)phenyl]-1-ethanone
CN109134318A
Cited By
Preparation method of 2-chloro-3-methyl-4-methylsulfonyl acetophenone
CN120590303A
